Pure Global AI
NCT06393569Recruiting

Sense of Security With Access to Palliative Outpatient Clinic

Experience of Security Having Access to Specialized Palliative Care Clinic
Region SkaneClinicalTrials.gov
Verified
Study focus
Disease/Condition
Cancer
Study type
Observational
Sponsor & location
Primary sponsor
Region Skane
Location
Lund, Sweden
Timeline & enrollment
Phase
N/A
Start date
Mar 14, 2024
End date
Mar 14, 2028
Enrollment
200 participants
Primary outcome

Experience of security and continuity

Summary

The aim of the study is to evaluate experience of security, accessibility, and avoidable
 utilization of health care services in patients who have had access to specialized palliative
 care clinic (SPCC) compared to those who have not, and to evaluate the relatives' experience
 of the care.

ICD-10 classifications
Carcinoid syndromeOther chemotherapyCarcinoma in situ, unspecifiedMalignant neoplasmsMalignant neoplasm: Prepuce
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06393569
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06393569 through Pure Global AI's free database. This phase not specified trial is sponsored by Region Skane and is currently Recruiting. The study focuses on Cancer. Target enrollment is 200 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.